REgulatory T Cell infuSion fOr Lung Injury Due to COVID-19 PnEumonia
Clinical trial NCT04468971 · COMPLETED
Trial details
- NCT number
- NCT04468971
- Sponsor
- Cellenkos, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-29
- Primary completion
- 2021-10-22
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.